By Teemo Chang and Stewart Eisenhart, Emergo Group
The China Food and Drug Administration (CFDA) has drafted a new batch of medium- and high-risk medical devices and IVDs slated for exemption from clinical trial requirements in the country.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.
The post China FDA adds more medical devices, IVDs to clinical trial exemptions list appeared first on MassDevice.